In an extraordinary breakthrough that could redefine the prophylactic landscape against respiratory syncytial virus (RSV), a team of researchers has demonstrated that maternal vaccination induces the production of high-affinity antibodies that are transferred with remarkable efficiency to infants, providing them with enhanced passive immunity during their most vulnerable early months. This pivotal study, published in […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.